- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00472147
Selection of Shock Energy in Out-Of-Hospital Cardiac Arrest
May 10, 2007 updated by: Charite University, Berlin, Germany
Sudden cardiac death is the most frequent cause of death in industrialized countries.
The most efficient interventiont in ventricular fibrillation is defibrillation in an appropriate timely manner.
But since the intervention of defibrillation the optimal shock energy is unknown.
As a too low energy is not able to terminate ventricular fibrillation a too high energy may cause asystole wich jeopardizes survival itself.
We study the efficacy of different shock energies on the termination of ventricular fibrillatiion and survival.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Dirk Müller, MD, PhD
- Phone Number: 3554 +49 30 8445
- Email: dr.dirk.mueller@charite.de
Study Contact Backup
- Name: Hans-Richard Arntz, MD, PhD
- Phone Number: 2640 +49 30 8445
- Email: hans-richard.arntz@charite.de
Study Locations
-
-
-
Berlin, Germany, 12200
- Charite Campus Benjamin Franklin
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- out of hospital sudden cardiac death
- ventricular fibrillation
Exclusion Criteria:
- non cardiac death
- asystole
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
---|
termination of vf survival
|
Secondary Outcome Measures
Outcome Measure |
---|
resulting rhythm CPC score
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Dirk Müller, MD, PhD, Charite University, Berlin, Germany
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
May 10, 2007
First Submitted That Met QC Criteria
May 10, 2007
First Posted (Estimate)
May 11, 2007
Study Record Updates
Last Update Posted (Estimate)
May 11, 2007
Last Update Submitted That Met QC Criteria
May 10, 2007
Last Verified
May 1, 2007
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CBF-2007002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arrhythmia
-
Medical University of LodzNot yet recruitingCardiac Arrhythmia | Supraventricular ArrhythmiaPoland
-
SanofiCompletedVentricular Arrhythmia | Arrhythmia ProphylaxisNetherlands, Spain, Belgium, Japan, Finland, Chile, Australia, United States, Argentina, Canada, Czech Republic, Denmark, France, Germany, Hungary, Israel, Italy, Mexico, Norway, Poland, Portugal, Russian Federation, Slovakia, South Africa and more
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases | Heart Failure | Arrhythmia | Heart Failure, Congestive | Sinus Arrhythmia
-
Ceryx Medical LtdCardiff and Vale University Health BoardNot yet recruitingHeart Failure With Reduced Ejection FractionUnited Kingdom
-
University of Wisconsin, MadisonNational Heart, Lung, and Blood Institute (NHLBI)Recruiting
-
Myant Medical Corp.Partners in Advanced Cardiac EvaluationCompleted
-
New York Institute of TechnologyCompleted
-
Atrial Fibrillation NetworkDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Preventicus GmbH; Corsano... and other collaboratorsCompletedAtrial ArrhythmiaGermany, Poland, Spain
-
Population Health Research InstituteBoston Scientific CorporationCompleted
-
MicroPort CRMCompletedAtrial ArrhythmiaUnited States, Germany, Spain, Denmark, Switzerland, France, Belgium, Australia, Japan, Italy, Canada, Netherlands
Clinical Trials on shock efficacy
-
University of OklahomaTerminated
-
amr bayoumi salamaCairo UniversityEnrolling by invitation
-
Mackay Memorial HospitalCompleted
-
Asociacion Colaboracion Cochrane IberoamericanaCompletedPain | Plantar FasciitisSpain
-
Rodrigo Marcel Valentim da SilvaUniversidade Federal do Rio Grande do NorteCompletedPain | Muscle Tonus
-
South Valley UniversityRecruitingShock Wave and Nitric OxideEgypt
-
Storz Medical AGTerminatedErectile DysfunctionGermany
-
Indústria Brasileira Equipamentos Médicos - IBRAMEDCompletedCellulitis | Adiposity | LipodystrophyBrazil
-
Northern Orthopaedic Division, DenmarkCompletedChronic Inflammatory Disorder
-
Yuzuncu Yıl UniversityCompleted